ARD-2128 is primarily utilized in the field of oncology research, where it serves as a potent inhibitor targeting specific pathways involved in cancer cell proliferation. Its application is particularly significant in preclinical studies aimed at understanding and disrupting the mechanisms that allow cancer cells to survive and grow. Researchers employ ARD-2128 to evaluate its efficacy in reducing tumor growth in various cancer models, providing insights into its potential as a therapeutic agent. Additionally, it is used in combination studies with other anticancer drugs to assess synergistic effects, which could lead to more effective treatment strategies. The compound is also valuable in molecular biology research, where it helps elucidate the role of specific proteins and pathways in cancer progression. Overall, ARD-2128 is a crucial tool in advancing the development of targeted cancer therapies.